Overview
Shou-man Wang practices practicing medicine in Changsha, China.
Wang is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Glycogen Storage Disease Type 13, Lactate Dehydrogenase Deficiency, HER-2 Positive Breast Cancer, and Triple-Negative Breast Cancer.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Shou-man Wang
Is Shou-man Wang a top-rated expert for Glycogen Storage Disease Type 13?
MediFind is an objective health platform that identifies experts based on real-world data. Shou-man Wang is classified as an Advanced expert for Glycogen Storage Disease Type 13, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Shou-man Wang participate in research or clinical trials?
Yes. Shou-man Wang has published 10 articles and abstracts on conditions like Glycogen Storage Disease Type 13. You can view a list of Shou-man Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Glycogen Storage Disease Type 13
- Experienced
- Breast CancerWang isExperienced. Learn about Breast Cancer.
- HER-2 Positive Breast Cancer
- Lactate Dehydrogenase Deficiency
- Triple-Negative Breast Cancer